Summary
Research published in Cell Reports (2022) developed adipose tissue spheroids that model obesity and metabolic dysfunction. 3D Petri Dish® enabled scalable production of uniform fat spheroids for drug screening.
Adipose Spheroids Model Metabolic Disease
Research Overview
Obesity affects metabolic function at the tissue level. This study created adipose tissue spheroids that recapitulate the inflammation and insulin resistance seen in obese patients, enabling drug discovery for metabolic diseases.
How 3D Petri Dish® Enabled This Research
Key Discoveries
- Adipose spheroids develop obesity-like metabolic dysfunction
- Model inflammation and insulin resistance
- Screen anti-obesity and diabetes drugs
- Patient-derived spheroids enable personalized medicine
3D Petri Dish® Application
Enabled scalable production of uniform adipose spheroids for metabolic research
- Uniform Fat Depots: Consistent spheroid size for metabolic measurements
- Long-Term Culture: Maintained adipocyte function over weeks
- Patient Cells: Compatible with primary human adipocytes
Frequently Asked Questions
Can adipose spheroids model obesity?
Yes, adipose spheroids treated with inflammatory factors develop insulin resistance and metabolic dysfunction similar to obese fat tissue.
Why use 3D adipose spheroids instead of 2D adipocytes?
3D spheroids maintain proper adipocyte morphology with lipid droplets and secrete adipokines at physiological levels, unlike flattened 2D cultures.
Which 3D Petri Dish is best for adipose research?
The 12-81 Large Spheroid Kit provides optimal size for adipose spheroids, which require larger volumes to accumulate lipid.